Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FHY1C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,299
Award facts
- Contract value 100% obligated
- $32,298.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,298.75 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price delivery order, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a non-competitive procurement utilizing an existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor indicated for the treatment of high cholesterol and cardiovascular disease prevention, representing a specialized pharmaceutical commodity within the DLA's medical supply portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves critical federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The contract reflects the company's established capability to fulfill specialized medication requirements through the DLA's pharmaceutical supply chain, supporting military personnel and veteran healthcare needs with brand-name pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FHY1C?
SPE2DR26FHY1C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DR26FHY1C worth?
The government has obligated $32,299 on SPE2DR26FHY1C.
Is contract SPE2DR26FHY1C an order under another contract?
Yes. SPE2DR26FHY1C is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY1C competed?
The extent of competition for SPE2DR26FHY1C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award